Enabling Clinical Translation of Astatine-211 Therapies: Overcoming CMC & Supply Chain Hurdles
- Overview of Astatine-211’s therapeutic potential in targeted alpha therapy
- Key CMC and supply chain hurdles in clinical-stage development
- Practical strategies to enable scalable, compliant manufacturing